Pharmafile Logo
Pharmafocus logo
Advanced Search
web_simon_bellamy_scm

SCM Pharma appoints new director

October 18, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing SCM Pharma, simon bellamy

Contract development and manufacturing organisation SCM Pharma has expanded its commercial management team with the appointment of a new director. …

Appointment

Astellas gets NICE nod

October 18, 2013
Sales and Marketing Cancer, NHS, NICE, Xtandi

Astellas Pharma’s new prostate cancer drug Xtandi which has been shown to shrink and kill cancer cells, has been recommended …

News
GSK China image

Travel ban ambiguity for GSK ‘s former China boss

October 17, 2013
Sales and Marketing China, GSK, bribery, reilly

GlaxoSmithKline has refuted reports that its former chief of Chinese operations is barred from leaving the country while he assists …

News
Quest diagnostics image

Quest starts selling BRCA tests

October 17, 2013
Sales and Marketing BRCA, Myriad, Quest, jolie

Quest Diagnostics has begun selling a genetic test to uncover the risk of hereditary breast cancer, after the US Supreme …

News

SHL to Inspire Innovation at the 2013 PDA Conference in Basel, Switzerland

October 17, 2013
Manufacturing and Production auto injector, auto-injector, autoinjector, autoinjector innovation, pen injector, shl pda basel

 

News
Press release

GCI Health expands with new London office

October 17, 2013
Medical Communications GCI Health, agency, comms

Healthcare communications agency GCI Health has officially opened its London office. The expansion, in response to the agency’s growing global …

News
HPV vaccine image

GAVI begins roll-out of cheap HPV vaccine

October 17, 2013
Sales and Marketing GAVI, HPV, Vaccine

For the first time women in parts of the world with the highest cervical cancer death rate will be able …

News
screen_shot_2013-10-17_at_08

Director appointed for MediCity

October 17, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing browning, medicity

Former chief executive of Philips Healthcare and Consumer Lifestyle David Browning has been appointed director of MediCity. The new Nottingham-based …

Appointment
Regeneron image

Phase III boost for alirocumab

October 17, 2013
Sales and Marketing LDL, Regeneron, alirocumab

Sanofi and Regeneron Pharmaceuticals are celebrating some upbeat data from their investigational treatment alirocumab, which has proved adept at tackling …

News
NHS image

Patients should ‘top up’ NHS costs

October 16, 2013
Sales and Marketing Dixon, England, NHS, NICE, top up

A leading doctor believes that NHS patients must produce top up payments for treatments for non-life threatening conditions. Speaking at …

News

Rare disease fund scrapped by NHS England

October 16, 2013
Research and Development, Sales and Marketing NHS England, fund, rare diseases

NHS England has pulled the plug on a £50 million fund to advance innovation in the investigation and treatment of …

News
mark_mcclellan_jj_fda

Former FDA commissioner joins J&J

October 16, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, J&J, JJ

Johnson & Johnson has announced that ex-FDA commissioner Mark McClellan has been appointed to its Board of directors. Dr McClellan …

Appointment
jj_2johnson_and_johnson

Johnson & Johnson posts strong Q3 results

October 16, 2013
Sales and Marketing J&J, JJ, Q3, Velcade, results

Johnson & Johnson has posted a strong set of financials for the third quarter as new products from its pharma …

News
set your sights image

Novartis launches Facebook ‘retina app’

October 15, 2013
Medical Communications AMD, Bayer, Lucentis, Novartis, set your sights

Novartis, the world’s biggest eye-care drugmaker, has launched a new Facebook retina app to raise awareness of retinal disease. The …

News
astrazeneca image

AstraZeneca pays $460m for cancer specialists

October 15, 2013
Research and Development, Sales and Marketing ADC, AstraZeneca, Cancer, MedImmune, spirogen

AstraZeneca’s biologics arm MedImmune has bought cancer biotech firm Spirogen and set up a licensing deal with ADC Therapeutics for …

News

Billions spent on European cancer care

October 15, 2013
Research and Development, Sales and Marketing Cancer, Europe, Lancet, Oxford, Pfizer

A new report has shown that cancer cost the European Union a total of €126 billion in 2009, with healthcare …

News
Pixuvri image

Price cut not enough for Pixuvri

October 15, 2013
Sales and Marketing Cell Therapeutics, NICE, pixuvri

NICE is still saying no to Cell Therapeutics’ lymphoma drug Pixuvri, despite the firm offering a discount on the treatment’s …

News
Roche image

Roche poised to get even bigger in biomanufacturing

October 15, 2013
Manufacturing and Production Jobs, Merck, Roche, cuts

Roche plans to invest a massive 800 million Swiss francs ($882m) over the next five years to increase manufacturing capacity …

News
ian_tomlinson_bia_web

String of appointments to BIA Board

October 15, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, appointments

The BioIndustry Association has appointed Kevin Cox, Donna Hackett, Jane Osbourn, Stephen Taylor, Patrick Verheyen and Tim Watts to its …

Appointment
Ranbaxy image

FDA throws Ranbaxy a manufacturing lifeline

October 15, 2013
Manufacturing and Production FDA, Ranbaxy, recall

Problems have plagued Ranbaxy’s manufacturing operations in the last couple of years, but it enjoyed a bit of light relief …

News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026